| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/29/2004 | WO2004050039A3 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 07/29/2004 | WO2004043336A3 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases |
| 07/29/2004 | WO2004037175A3 Compositions and methods for treating human papillomavirus-mediated disease |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004032873A3 Therapeutic combination of carnitine and antioxidant polyphenols |
| 07/29/2004 | WO2004016218A3 Medical decision support systems utilizing gene expression and clinical information and method for use |
| 07/29/2004 | WO2004014315A3 Selective plasma exchange therapy |
| 07/29/2004 | WO2004002426A3 Identification of imprints on dosage forms |
| 07/29/2004 | WO2003028634A8 Method of treatment using ligand-immunogen conjugates |
| 07/29/2004 | WO2003022123A3 Methods of kidney transplantation utilizing developing nephric tissue |
| 07/29/2004 | US20040147629 Antimicrobial suture coating |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147594 Compositions and products containing R-equol, and methods for their making |
| 07/29/2004 | US20040147581 Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
| 07/29/2004 | US20040147541 Using rapamycin; antitumor agents; angiogenesis inhibitors |
| 07/29/2004 | US20040147509 Method of treating functional bowel disorders |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147464 For therapy |
| 07/29/2004 | US20040146949 contacting a first sample of cells with CD40 ligand and measuring the level or amount of a marker; contacting a second sample of cells with a compound and CD40 ligand and measuring the level or amount of a marker; comparing level of marker in both |
| 07/29/2004 | US20040146591 Solvent extraction, mixing with aqueous solution; drying; sterilization; drugs, food; aging resistance, cognition activators , brain disorders; incontinence; Alzheimer's disease, autism, Parkinson's disease, antiarthritic agents |
| 07/29/2004 | US20040146557 Liquid polymeric compositions for controlled release of bioactive substances |
| 07/29/2004 | US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 07/29/2004 | US20040144976 Light emitting diode, support & method of manufacture |
| 07/29/2004 | CA2513277A1 Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 07/29/2004 | CA2513249A1 Method for in vivo regulation of cardiac muscle contractility |
| 07/29/2004 | CA2512983A1 Method of treating functional bowel disorders |
| 07/29/2004 | CA2512974A1 Soluble fc.gamma.r fusion proteins and methods of use thereof |
| 07/29/2004 | CA2512812A1 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 07/29/2004 | CA2512717A1 Compositions and methods for targeted biological delivery of molecular carriers |
| 07/29/2004 | CA2512673A1 2-o sulfatase compositions and related methods |
| 07/29/2004 | CA2512672A1 Methods of treating lung diseases |
| 07/29/2004 | CA2512666A1 Combination therapy for anticoagulation |
| 07/29/2004 | CA2512545A1 Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
| 07/29/2004 | CA2511659A1 Methods for reducing mortality associated with acute myocardial infarction |
| 07/29/2004 | CA2511530A1 Night-time oral insulin therapy |
| 07/29/2004 | CA2510382A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | CA2509251A1 Method of treating cognitive decline due to sleep deprivation and stress |
| 07/28/2004 | EP1440686A1 Aerosol compositions |
| 07/28/2004 | EP1439870A2 Method and device for the delivery of a substance |
| 07/28/2004 | EP1439864A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/28/2004 | EP1439838A1 Macrolides containing pharmaceutical compositions |
| 07/28/2004 | EP1439823A1 Pharmaceutical formulation comprising (r)-bicalutamide |
| 07/28/2004 | EP1030673B1 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | CN1515286A Chinese medicinal herb extractive |
| 07/28/2004 | CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives |
| 07/28/2004 | CN1159014C Use of 4 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis |
| 07/28/2004 | CN1158997C A process for the preparation of suspensions of drug particles for inhalation delivery |
| 07/27/2004 | US6767561 Plant extracts as antiproliferative, viricides and antiparasitic agents |
| 07/27/2004 | CA2331261C 2"-deoxy hygromycin derivatives |
| 07/22/2004 | WO2004061084A2 Modulation of protein functionalities |
| 07/22/2004 | WO2004060321A2 Cardioprotective delta opioid receptor agonists and methods of using same |
| 07/22/2004 | WO2004060317A2 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
| 07/22/2004 | WO2004060316A2 Irs modulators |
| 07/22/2004 | WO2004060315A2 Stable topical drug delivery compositions |
| 07/22/2004 | WO2004060313A2 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 07/22/2004 | WO2004060310A2 Human growth hormone crystals and methods for preparing them |
| 07/22/2004 | WO2004060309A2 Methods of treating and/or preventing autoimmune diseases |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004060306A2 Anti-inflammatory medicaments |
| 07/22/2004 | WO2004060305A2 Anti-cancer medicaments |
| 07/22/2004 | WO2004060304A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060302A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | WO2004060298A2 Fast dissolving films for oral administration of drugs |
| 07/22/2004 | WO2004060295A2 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | WO2004060293A2 Methods and compositions for protection against thrombolysis-associated reperfusion injury |
| 07/22/2004 | WO2004060291A2 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | WO2004060283A2 Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
| 07/22/2004 | WO2004060282A2 Uses of the snorf207 receptor |
| 07/22/2004 | WO2004060280A2 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 07/22/2004 | WO2004060278A2 Methods for rapid identification of pathogens in humans and animals |
| 07/22/2004 | WO2004060274A2 Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells |
| 07/22/2004 | WO2004060267A2 A process for producing enriched fractions containing up to 100% of bacoside a and bacoside b |
| 07/22/2004 | WO2004060266A2 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 07/22/2004 | WO2004060265A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | WO2004060263A2 Magnesium salt of imidazole derivative |
| 07/22/2004 | WO2004060262A2 Modulators of notch signalling for use in immunotherpapy |
| 07/22/2004 | WO2004043339A3 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 07/22/2004 | WO2004041202A3 Analysis of pharmaceutical solubility and stability |
| 07/22/2004 | WO2004039330A3 Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls |
| 07/22/2004 | WO2004039313A3 Preventing desensitization of receptors |
| 07/22/2004 | WO2004037203A9 Sustained release l-arginine formulations and methods of manufacture and use |
| 07/22/2004 | WO2004037186A8 Prophylactic treatment methods |
| 07/22/2004 | WO2004026253A3 Novel lapacho compounds and methods of use thereof |
| 07/22/2004 | WO2004024086A3 Compounds, compositions and methods |
| 07/22/2004 | WO2004019881A9 Hypocretin administration as a treatment for obesity |
| 07/22/2004 | WO2004019860A3 Formulations of modified antibodies and methods of making the same |
| 07/22/2004 | WO2003045310A9 Digital assay |
| 07/22/2004 | WO2003017919A3 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 07/22/2004 | US20040142983 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 07/22/2004 | US20040142945 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 07/22/2004 | US20040142931 inhibit the tyrosine kinase activity of growth factor receptors such as HER1, HER2, and HER4 |
| 07/22/2004 | US20040142904 Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof |
| 07/22/2004 | US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 07/22/2004 | US20040142038 Three layer artificial tear formulation |
| 07/22/2004 | US20040141955 Compositions related to a novel endophytic fungi and methods of use |
| 07/22/2004 | US20040141928 Composition |
| 07/22/2004 | CA2552261A1 Cardioprotective delta opioid receptor agonists and methods of using same |